Clinic Conversation Of The Week: How To Talk To Patients About The BENEFIT Trial In Multiple Myeloma Oncology Data Advisor podcast

Artwork

Oncology Medicine Science Oncology Data Advisor I3 Health

Innhold levert av Oncology Data Advisor® and I3 Health. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Data Advisor® and I3 Health eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Oncology Data Advisor « »
Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma

2M ago 5:36

Del

MP3•Episoder hjem

Innhold levert av Oncology Data Advisor® and I3 Health. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Data Advisor® and I3 Health eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do I tell them?

… continue reading

409 episoder

#Oncology #Medicine #Science #Oncology Data Advisor #I3 Health

Artwork

Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma

Oncology Data Advisor

43 subscribers

published 2M ago

Del

MP3•Episoder hjem

Innhold levert av Oncology Data Advisor® and I3 Health. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Data Advisor® and I3 Health eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do I tell them?

… continue reading

409 episoder

#Oncology #Medicine #Science #Oncology Data Advisor #I3 Health

Alle Folgen

×

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

Lytt til 500+ tema

Lytt til dette showet mens du utforsker